European Union · Record · QUESTION_WRITTEN_PRIORITY
P-10-2025-000624
Why did the Pfizer/BionTech agreement waive serialisation?
Introduced
11 February 2025
Last action
6 April 2025 · Answer
Status
answered
Sponsors
Christine ANDERSON
Subjects
Discovery layer
Source updated
6 April 2025
Records
Official record P-10-2025-000624 from European Union at European Parliament. Dated 11 February 2025. Status: answered.
Timeline
11 February 2025
Written question
Why did the Pfizer/BionTech agreement waive serialisation?
Source: QUESTION_WRITTEN_PRIORITY
6 April 2025
Answer
Source: QUESTION_WRITTEN_ANSWER
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
Answer
This file cannot be previewed here. Use View or Download.
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Answer
QUESTION_WRITTEN_ANSWER · 6 April 2025
Why did the Pfizer/BionTech agreement waive serialisation?
QUESTION_WRITTEN_PRIORITY · EN · 17 February 2025
DownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Why did the Pfizer/BionTech agreement waive serialisation?
QUESTION_WRITTEN_PRIORITY · EN · 17 February 2025
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Warum wurde in der Vereinbarung mit Pfizer/BioNTech auf eine Serialisierung verzichtet?
QUESTION_WRITTEN_PRIORITY · DE · 17 February 2025
DownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Warum wurde in der Vereinbarung mit Pfizer/BioNTech auf eine Serialisierung verzichtet?
QUESTION_WRITTEN_PRIORITY · DE · 17 February 2025
ViewDownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Sponsors
- · COM · ADDRESSEE
- Christine ANDERSON · AUTHOR
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.europarl.europa.eu/doceo/document/P-10-2025-000624_EN.html
- Open data entity: https://data.europarl.europa.eu/api/v2/parliamentary-questions/P-10-2025-000624
- eu · P-10-2025-000624 · source updated 6 April 2025